$SLNG
Stabilis Solutions, Inc. Stock $slng

$slng Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000143774924015119 Filed on May 07, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$18.60M	$19.77M	$26.84M
YoY Change	44.09%	-26.35%	16.54%
Cost Of Revenue	$13.55M	$13.51M	$20.27M
YoY Change	28.01%	-33.33%	15.06%
Gross Profit	$5.048M	$6.256M	$6.572M
YoY Change	117.4%	-4.81%	21.34%
Gross Profit Margin	27.14%	31.64%	24.48%
Selling, General & Admin	$3.331M	$3.456M	$3.379M
YoY Change	9.46%	2.28%	-5.24%
% of Gross Profit	65.99%	55.24%	51.42%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.800M	$1.800M	$2.011M
YoY Change	-10.0%	-10.49%	-13.39%
% of Gross Profit	35.66%	28.77%	30.6%
Operating Expenses	$3.331M	$3.456M	$3.379M
YoY Change	9.46%	2.28%	-5.24%
Operating Profit	$1.717M	$2.800M	$3.193M
YoY Change	-338.14%	-12.31%	72.59%
Interest Expense	$405.0K	$445.0K	-$6.000K
YoY Change	-45.12%	-7516.67%	-93.88%
% of Operating Profit	23.59%	15.89%	-0.19%
Other Income/Expense, Net	$54.00K	-$25.00K	-$266.0K
YoY Change	-125.59%	-90.6%	15.65%
Pretax Income	$452.0K	$1.551M	$1.092M
YoY Change	-122.43%	42.03%	-304.11%
Income Tax	$425.0K	$82.00K	$8.000K
% Of Pretax Income	94.03%	5.29%	0.73%
Net Earnings	$27.00K	$1.469M	$1.084M
YoY Change	-101.24%	35.52%	-367.0%
Net Earnings / Revenue	0.15%	7.43%	4.04%
Basic Earnings Per Share	$0.00	$0.08	$0.06
Diluted Earnings Per Share	$0.00	$0.08	$0.06
COMMON SHARES
Basic Shares Outstanding	18.59M	18.59M	18.43M shares
Diluted Shares Outstanding	18.59M	18.58M	18.52M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.48M	$8.286M	$6.861M
YoY Change	41.4%	20.77%	170.01%
Cash & Equivalents	$11.48M	$8.286M	$6.861M
Short-Term Investments
Other Short-Term Assets	$145.0K	$157.0K	$1.299M
YoY Change	113.24%	-87.91%	-16.68%
Inventory	$155.0K	$137.0K	$70.00K
Prepaid Expenses
Receivables	$5.933M	$5.620M	$9.696M
Other Receivables	$284.0K	$275.0K	$103.0K
Total Short-Term Assets	$18.90M	$15.49M	$18.03M
YoY Change	35.15%	-14.11%	17.22%
LONG-TERM ASSETS
Property, Plant & Equipment	$48.37M	$48.62M	$52.49M
YoY Change	-6.07%	-7.38%	-3.23%
Goodwill	$4.314M	$4.314M	$4.314M
YoY Change	0.0%	0.0%	-3.12%
Intangibles
YoY Change
Long-Term Investments	$10.54M	$11.78M	$12.09M
YoY Change	-7.04%	-2.58%	-3.45%
Other Assets			$563.0K
YoY Change			59.49%
Total Long-Term Assets	$63.68M	$65.16M	$68.90M
YoY Change	-5.94%	-5.42%	-3.26%
TOTAL ASSETS
Total Short-Term Assets	$18.90M	$15.49M	$18.03M
Total Long-Term Assets	$63.68M	$65.16M	$68.90M
Total Assets	$82.57M	$80.65M	$86.93M
YoY Change	1.1%	-7.22%	0.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.607M	$5.811M	$3.173M
YoY Change	266.04%	83.14%	-39.31%
Accrued Expenses	$3.614M	$2.432M	$10.68M
YoY Change	-64.47%	-77.23%	44.12%
Deferred Revenue			$1.406M
YoY Change			346.35%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.216M	$1.657M	$2.328M
YoY Change	-22.7%	-28.82%	17.22%
Total Short-Term Liabilities	$11.52M	$10.01M	$16.34M
YoY Change	-16.04%	-38.72%	9.39%
LONG-TERM LIABILITIES
Long-Term Debt	$7.378M	$7.446M	$8.661M
YoY Change	-11.63%	-14.03%	11.21%
Other Long-Term Liabilities	$0.00	$0.00	$89.00K
YoY Change		-100.0%	-1.11%
Total Long-Term Liabilities	$7.378M	$7.446M	$8.750M
YoY Change	-11.63%	-14.9%	11.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.52M	$10.01M	$16.34M
Total Long-Term Liabilities	$7.378M	$7.446M	$8.750M
Total Liabilities	$18.90M	$17.46M	$25.20M
YoY Change	-14.69%	-30.72%	0.63%
SHAREHOLDERS EQUITY
Retained Earnings	-$38.75M	-$38.78M	-$39.29M
YoY Change	-6.54%	-1.3%	4.51%
Common Stock	$19.00K	$19.00K	$100.7M
YoY Change	0.0%	-99.98%	2.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$63.68M	$63.19M	$61.73M
YoY Change
Total Liabilities & Shareholders Equity	$82.57M	$80.65M	$86.93M
YoY Change	1.1%	-7.22%	0.37%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	$27.00K	$1.469M	$1.084M
YoY Change	-101.24%	35.52%	-367.0%
Depreciation, Depletion And Amortization	$1.800M	$1.800M	$2.011M
YoY Change	-10.0%	-10.49%	-13.39%
Cash From Operating Activities	$5.038M	$3.929M	$93.00K
YoY Change	32.27%	4124.73%	-95.84%
INVESTING ACTIVITIES
Capital Expenditures	$1.376M	$873.0K	$3.727M
YoY Change	-7.28%	-76.58%	305.99%
Acquisitions
YoY Change
Other Investing Activities	$72.00K	$207.0K	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$1.304M	-$666.0K	-$3.727M
YoY Change	-12.13%	-82.13%	355.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-529.0K	-$355.0K	-$961.0K
YoY Change	-50.93%	-63.06%	-15.11%
NET CHANGE
Cash From Operating Activities	5.038M	$3.929M	$93.00K
Cash From Investing Activities	-1.304M	-$666.0K	-$3.727M
Cash From Financing Activities	-529.0K	-$355.0K	-$961.0K
Net Change In Cash	3.205M	$2.912M	-$4.590M
YoY Change	157.02%	-163.44%	-1054.26%
FREE CASH FLOW
Cash From Operating Activities	$5.038M	$3.929M	$93.00K
Capital Expenditures	$1.376M	$873.0K	$3.727M
Free Cash Flow	$3.662M	$3.056M	-$3.634M
YoY Change	57.51%	-184.09%	-375.3%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	37500000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	37500000
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18585014
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18585014
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18573391
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18573391
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	0	usd
CY2023Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	32000	usd
CY2021Q2	us-gaap	Debt Instrument Variable Interest Rate Type Extensible Enumeration DebtInstrumentVariableInterestRateTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#PrimeRateMember
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-40364
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	59-3410234
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	11750 Katy Freeway, Suite 900
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77079
CY2024Q1	dei	City Area Code CityAreaCode	832
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	456-6500
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, $.001 par value
CY2024Q1	dei	Trading Symbol TradingSymbol	SLNG
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	18585014
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8286000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5374000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5620000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7752000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	137000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	169000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1442000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1677000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	15485000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	14972000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	111435000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	110646000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	62819000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	61167000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	48616000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	49479000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	4314000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	4314000	usd
CY2024Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	11780000	usd
CY2023Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	12009000	usd
CY2024Q1	slng	Right Of Use Assets And Other Assets Noncurrent RightOfUseAssetsAndOtherAssetsNoncurrent	452000	usd
CY2023Q4	slng	Right Of Use Assets And Other Assets Noncurrent RightOfUseAssetsAndOtherAssetsNoncurrent	525000	usd
CY2024Q1	us-gaap	Assets Assets	80647000	usd
CY2023Q4	us-gaap	Assets Assets	81299000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	5811000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5707000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2432000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4166000	usd
CY2024Q1	slng	Finance Lease And Operating Lease Liability Current FinanceLeaseAndOperatingLeaseLiabilityCurrent	112000	usd
CY2023Q4	slng	Finance Lease And Operating Lease Liability Current FinanceLeaseAndOperatingLeaseLiabilityCurrent	164000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	10012000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11719000	usd
CY2024Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	7446000	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	7747000	usd
CY2024Q1	slng	Finance Lease And Operating Lease Liability Noncurrent FinanceLeaseAndOperatingLeaseLiabilityNoncurrent	0	usd
CY2023Q4	slng	Finance Lease And Operating Lease Liability Noncurrent FinanceLeaseAndOperatingLeaseLiabilityNoncurrent	21000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	17458000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	19487000	usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	19000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	19000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	102431000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	102057000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-484000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-18000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38777000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-40246000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	63189000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	61812000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	80647000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	81299000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19770000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	26842000	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	13514000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	20270000	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	252000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-169000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3456000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3379000	usd
CY2024Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	127000	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-0	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1800000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2011000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	18391000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	25829000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1379000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1013000	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	247000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	393000	usd
CY2024Q1	slng	Operations Related Expense Foreign Joint Venture OperationsRelatedExpenseForeignJointVenture	50000	usd
CY2023Q1	slng	Operations Related Expense Foreign Joint Venture OperationsRelatedExpenseForeignJointVenture	48000	usd
CY2024Q1	slng	Equity Income Foreign Joint Venture Net EquityIncomeForeignJointVentureNet	197000	usd
CY2023Q1	slng	Equity Income Foreign Joint Venture Net EquityIncomeForeignJointVentureNet	345000	usd
CY2024Q1	slng	Income Loss From Continuing Operations Before Nonoperating Income Expense Income Taxes Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeNonoperatingIncomeExpenseIncomeTaxesNoncontrollingInterest	1576000	usd
CY2023Q1	slng	Income Loss From Continuing Operations Before Nonoperating Income Expense Income Taxes Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeNonoperatingIncomeExpenseIncomeTaxesNoncontrollingInterest	1358000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-21000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-84000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-25000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-266000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1551000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1092000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	82000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	1469000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1084000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	1469000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1084000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-466000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	187000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1003000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1271000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	59867000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	589000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1084000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	187000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	61727000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	61812000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	0	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	383000	usd
CY2024Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	9000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	1469000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-466000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	63189000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	1469000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1084000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1800000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2011000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	383000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	589000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	168000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	127000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-0	usd
CY2024Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	247000	usd
CY2023Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	393000	usd
CY2024Q1	us-gaap	Realized And Unrealized Gain Loss Investment And Derivative Operating After Tax RealizedAndUnrealizedGainLossInvestmentAndDerivativeOperatingAfterTax	-0	usd
CY2023Q1	us-gaap	Realized And Unrealized Gain Loss Investment And Derivative Operating After Tax RealizedAndUnrealizedGainLossInvestmentAndDerivativeOperatingAfterTax	-421000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1964000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2044000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-235000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-507000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1812000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-6361000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-96000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-191000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3929000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	93000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	873000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3727000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	207000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-666000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3727000	usd
CY2024Q1	slng	Repayments Of Shortterm And Longterm Notes Payable RepaymentsOfShorttermAndLongtermNotesPayable	346000	usd
CY2023Q1	slng	Repayments Of Shortterm And Longterm Notes Payable RepaymentsOfShorttermAndLongtermNotesPayable	365000	usd
CY2024Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	-0	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	596000	usd
CY2024Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	9000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	-0	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-355000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-961000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2912000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4590000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5374000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11451000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8286000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6861000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	26842000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Use of Estimates in the Preparation of the Consolidated Financial Statements </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:23pt;">The preparation of the Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates include the fair value of natural gas derivatives, the carrying amount of contingencies, valuation allowances for receivables, inventories, and deferred income tax assets, valuations assigned to assets and liabilities in business combinations, and impairments of long-lived assets. Actual results could differ from those estimates, and these differences could be material to the Condensed Consolidated Financial Statements.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:23pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"></p>
CY2024Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Reclassifications</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:23pt;">The Company reclassified $4.2 million from accrued expenses to accounts payable at <em style="font: inherit;"> December 31, 2023, </em>to conform to current presentation resulting in <em style="font: inherit;">no</em> effect to results of operations or cash flows.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:23pt;"> </p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></p>
CY2024Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	0	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19770000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	26842000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19770000	usd
CY2024Q1	us-gaap	Prepaid Insurance PrepaidInsurance	671000	usd
CY2023Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1012000	usd
CY2024Q1	us-gaap	Supplies Supplies	196000	usd
CY2023Q4	us-gaap	Supplies Supplies	132000	usd
CY2024Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	275000	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	159000	usd
CY2024Q1	us-gaap	Deposit Assets DepositAssets	143000	usd
CY2023Q4	us-gaap	Deposit Assets DepositAssets	237000	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	157000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	137000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1442000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1677000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	111435000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	110646000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	62819000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	61167000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	48616000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	49479000	usd
CY2024Q1	us-gaap	Depreciation Depreciation	1800000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	2000000	usd
CY2024Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	32000	usd
CY2024Q1	us-gaap	Equity Method Investment Difference Between Carrying Amount And Underlying Equity EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity	1165000	usd
CY2023Q4	us-gaap	Equity Method Investment Difference Between Carrying Amount And Underlying Equity EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity	1165000	usd
CY2024Q1	slng	Equity Method Investment Accumulated Accretion EquityMethodInvestmentAccumulatedAccretion	605000	usd
CY2023Q4	slng	Equity Method Investment Accumulated Accretion EquityMethodInvestmentAccumulatedAccretion	573000	usd
CY2024Q1	slng	Equity Method Investment Net Remaining Basis Difference EquityMethodInvestmentNetRemainingBasisDifference	560000	usd
CY2023Q4	slng	Equity Method Investment Net Remaining Basis Difference EquityMethodInvestmentNetRemainingBasisDifference	592000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1545000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3276000	usd
CY2024Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	507000	usd
CY2023Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	354000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	380000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	536000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2432000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4166000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	9103000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	9429000	usd
CY2024Q1	us-gaap	Debt Current DebtCurrent	1657000	usd
CY2023Q4	us-gaap	Debt Current DebtCurrent	1682000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7446000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7747000	usd
CY2024Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	100000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	200000	usd
CY2024Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	100000	usd
CY2023Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	0	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	400000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	600000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	0
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18578815
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18426408
CY2024Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1996
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	91509
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18580811
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18517917
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	1469000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1084000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.06
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	157000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	182000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-0	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-0	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	182000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3000000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001437749-24-015119-index-headers.html	Edgar Link	pending
0001437749-24-015119-index.html	Edgar Link	pending
0001437749-24-015119.txt	Edgar Link	pending
0001437749-24-015119-xbrl.zip	Edgar Link	pending
ex_642192.htm	Edgar Link	pending
ex_642193.htm	Edgar Link	pending
ex_642194.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
logo01.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
slng-20240331.xsd	Edgar Link	pending
slng20240331_10q.htm	Edgar Link	pending
slng-20240331_cal.xml	Edgar Link	unprocessable
slng-20240331_def.xml	Edgar Link	unprocessable
slng-20240331_pre.xml	Edgar Link	unprocessable
slng-20240331_lab.xml	Edgar Link	unprocessable
slng20240331_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SLNG
Stabilis Solutions, Inc. Stock $slng

2024 Q2 Form 10-Q Financial Statement

#000143774924015119 Filed on May 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SLNG Stabilis Solutions, Inc. Stock $slng

2024 Q2 Form 10-Q Financial Statement

#000143774924015119 Filed on May 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SLNG
Stabilis Solutions, Inc. Stock $slng